Skip to content
10-K

Annual Report

STEADYMED LTD.

0001047469-18-002396

← back to feed
Filed
Mar 30, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Mar 15, 2018 26.57M sh
Capex FY 2017 · Dec 31, 2017 $1.71M
Capex FY 2017 · Dec 31, 2016 $2.38M
Operating Cash Flow FY 2017 · Dec 31, 2017 −$22.24M
Operating Cash Flow FY 2017 · Dec 31, 2016 −$25.85M
Cash And Equivalents FY 2017 · Dec 31, 2017 $32.45M
Cash And Equivalents FY 2017 · Dec 31, 2016 $23.22M
Cash And Equivalents FY 2017 · Dec 31, 2015 $31.85M
Stockholders Equity FY 2017 · Dec 31, 2017 $23.81M
Stockholders Equity FY 2017 · Dec 31, 2016 $14.31M
Stockholders Equity FY 2017 · Dec 31, 2015 $28.55M
Current Liabilities FY 2017 · Dec 31, 2017 $2.76M
Current Liabilities FY 2017 · Dec 31, 2016 $6.36M
Current Assets FY 2017 · Dec 31, 2017 $32.96M
Current Assets FY 2017 · Dec 31, 2016 $23.38M
Total Assets FY 2017 · Dec 31, 2017 $38.49M
Total Assets FY 2017 · Dec 31, 2016 $28.16M
Sga Expense FY 2017 · Dec 31, 2017 $5.15M
Sga Expense FY 2017 · Dec 31, 2016 $5.64M
Rd Expense FY 2017 · Dec 31, 2017 $14.61M
Rd Expense FY 2017 · Dec 31, 2016 $20.9M
Net Income FY 2017 · Dec 31, 2017 −$23.21M
Net Income FY 2017 · Dec 31, 2016 −$25.87M
Operating Income FY 2017 · Dec 31, 2017 −$20.44M
Operating Income FY 2017 · Dec 31, 2016 −$27.4M
Revenue FY 2017 · Dec 31, 2017 $1.07M
Revenue FY 2017 · Dec 31, 2016 $1.07M